Valuation APTOCROM Inc.

Stocks

End-of-day quote Korea S.E. 2026-10-08			5-day change	1st Jan Change
1,927.00 ^KRW	+2.77%		+3.21%	-61.46%

09-22	Aprogen Medicines Inc. announced that it has received KRW 20 billion in funding from N2Tech Co.,Ltd, APTOCROM Inc., Aprogen Pharma Inc.	CI
09-03	Aprogen Medicines Inc. announced that it expects to receive KRW 20 billion in funding from N2Tech Co.,Ltd, APTOCROM Inc., Aprogen Pharma Inc.	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025
Market Cap ¹	132,471	125,151	66,950	51,548	104,593	55,188
Change	-	-5.53%	-46.5%	-23.01%	102.9%	-47.23%
Enterprise Value (EV) ¹	101,306	69,004	-14,380	55,057	79,526	37,996
Change	-	-31.89%	-120.84%	482.87%	44.44%	-52.22%
P/E	12x	47.2x	-11.9x	24x	-2.12x	-9.5x
PBR	0.57x	0.56x	0.34x	0.31x	0.35x	0.18x
PEG	-	-0.6x	0x	-0x	0x	0.1x
Capitalization / Revenue	12.8x	14.9x	6.98x	3.22x	6.38x	5.63x
EV / Revenue	9.82x	8.2x	-1.5x	3.44x	4.85x	3.87x
EV / EBITDA	4,671x	-31.8x	1.22x	-2.69x	83.9x	-2.32x
EV / EBIT	-270x	-26.8x	1.19x	-2.62x	154x	-2.27x
EV / FCF	-1.98x	5.77x	-0.46x	13.1x	-32.9x	-1.9x
FCF Yield	-50.6%	17.3%	-216%	7.65%	-3.04%	-52.7%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	6,200	1,484	-3,140	648.5	-4,924	-526.5
Distribution rate	-	-	-	-	-	-
Net sales ¹	10,319	8,416	9,598	16,007	16,400	9,807
EBITDA ¹	21.69	-2,167	-11,810	-20,454	947.7	-16,372
EBIT ¹	-375.2	-2,579	-12,099	-21,004	517.3	-16,737
Net income ¹	11,084	2,650	-5,607	4,304	-28,094	-5,559
Net Debt ¹	-31,165	-56,147	-81,330	3,509	-25,067	-17,192
Reference price ²	74,200.00	70,100.00	37,500.00	15,580.00	10,420.00	5,000.00
Nbr of stocks (in thousands)	1,785	1,785	1,785	3,309	10,038	11,038
Announcement Date	3/15/21	3/14/22	3/17/23	3/13/24	3/14/25	3/20/26

¹KRW in Million²KRW

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
APTOCROM INC.	-	-	-	-	21.73M
ELI LILLY AND COMPANY	33.55x	12.18x	25.21x	0.58%	1,051B
JOHNSON & JOHNSON	29.08x	6.43x	18.37x	2.04%	630B
ABBVIE INC.	35.19x	8.13x	16.76x	2.51%	489B
MERCK & CO., INC.	105.8x	5.93x	25.27x	2.34%	359B
ROCHE HOLDING AG	19.31x	4.72x	11.72x	2.8%	344B
NOVARTIS AG	20.06x	5.27x	12.98x	3.02%	272B
ASTRAZENECA PLC	20.57x	4.22x	12.06x	2.1%	246B
AMGEN INC.	26.34x	6.83x	12.21x	2.43%	224B
GILEAD SCIENCES, INC.	-45.84x	6.75x	26.31x	2.18%	187B
Average	27.12x	6.72x	17.88x	2.22%	380.37B
Weighted average by Cap.	32.41x	7.85x	19.34x	1.9%